Education
About Us
Working with TipRanks
Follow Us
PharmaNutra SpA (IT:PHN)
:PHN
Total Valuation
PharmaNutra SpA has a market cap or net worth of €522.77M. The enterprise value is ―.
Market Cap€522.77M
Enterprise Value―
Share Statistics
PharmaNutra SpA has 9,680,977 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,680,977
Owned by Insiders34.54%
Owned by Institutions―
Financial Efficiency
PharmaNutra SpA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee856.22K
Profits Per Employee108.75K
Employee Count118
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of PharmaNutra SpA is ―. PharmaNutra SpA’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, PharmaNutra SpA had revenue of 101.03M and earned 12.83M in profits. Earnings per share was 1.33.
Revenue101.03M
Gross Profit48.95M
Operating Income23.36M
Pretax Income23.26M
Net Income12.83M
EBITDA26.53M
Earnings Per Share (EPS)1.33
Cash Flow
In the last 12 months, operating cash flow was 22.87M and capital expenditures -3.45M, giving a free cash flow of 19.42M billion.
Operating Cash Flow22.87M
Free Cash Flow19.42M
Free Cash Flow per Share2.01
Dividends & Yields
PharmaNutra SpA pays an annual dividend of €1, resulting in a dividend yield of 1.57%
Dividend Per Share€1
Dividend Yield1.57%
Payout Ratio58.48%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change8.70%
50-Day Moving Average51.12
200-Day Moving Average52.24
Relative Strength Index (RSI)65.61
Average Volume (3m)7.03K
Important Dates
PharmaNutra SpA upcoming earnings date is May 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 14, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend DateMay 05, 2025
Financial Position
PharmaNutra SpA as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, PharmaNutra SpA has paid 10.43M in taxes.
Income Tax10.43M
Effective Tax Rate―
Enterprise Valuation
PharmaNutra SpA EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
PharmaNutra SpA has €24.40M in cash and marketable securities with €0.00 in debt, giving a net cash position of -€24.40M billion.
Cash & Marketable Securities€24.40M
Total Debt€0.00
Net Cash-€24.40M
Net Cash Per Share-€2.52
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for PharmaNutra SpA is €83.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€83.00
Price Target Upside53.42% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast15.27%
EPS Growth Forecast29.51%